# Response Prediction to Neoadjuvant Chemoradiation in Esophageal Cancer Using Artificial Intelligence & Machine Learning

> **NCT04489368** · — · UNKNOWN · sponsor: **Dr Kundan Singh Chufal** · enrollment: 150 (estimated)

## Conditions studied

- Esophageal Neoplasm

## Interventions

- **RADIATION:** Neo-Adjuvant Radiotherapy
- **DRUG:** Neo-Adjuvant Chemotherapy
- **PROCEDURE:** Esophagectomy

## Key facts

- **NCT ID:** NCT04489368
- **Lead sponsor:** Dr Kundan Singh Chufal
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-16
- **Primary completion:** 2023-07
- **Final completion:** 2023-07
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2022-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04489368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04489368, "Response Prediction to Neoadjuvant Chemoradiation in Esophageal Cancer Using Artificial Intelligence & Machine Learning". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04489368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*